Schein, Jeff
Otsuka (United States) · Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)
8 papers on CoChatORCID 0009-0006-7892-5005
Most cited papers
- Verified
Validity of the Brief Pain Inventory for Use in Documenting the Outcomes of Patients With Noncancer Pain
Keller, S., Bann, C. M., Dodd, S. L., Schein, J., Mendoza, T. R., & Cleeland, C. S. (2004) · The Clinical Journal of Pain
Musculoskeletal pain and rehabilitationPain Management and Opioid Use
Cited by 1,233
- Verified
The economic burden of posttraumatic stress disorder in the United States from a societal perspective
Davis, L. L., Schein, J., Cloutier, M., Gagnon-Sanschagrin, P., Maitland, J., Urganus, A., Guerin, A., Lefebvre, P., & Houle, C. R. (2022) · The Journal of Clinical Psychiatry
Posttraumatic Stress Disorder ResearchHealth Systems, Economic Evaluations, Quality of Life
Cited by 259
- Verified
Persistent Nonmalignant Pain and Analgesic Prescribing Patterns in Elderly Nursing Home Residents: (See editorial comments by Dr. Debra Weiner on pp 1020–1022)
Won, A. B., Lapane, K. L., Vallow, S., Schein, J., Morris, J. N., & Lipsitz, L. A. (2004) · Journal of the American Geriatrics Society
Pain Management and Opioid UsePharmaceutical Practices and Patient Outcomes
Cited by 239
- Verified
Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective
Schein, J., Adler, L. A., Childress, A., Gagnon-Sanschagrin, P., Davidson, M., Kinkead, F., Cloutier, M., Guérin, A., & Lefebvre, P. (2022) · Journal of Managed Care & Specialty Pharmacy
Attention Deficit Hyperactivity DisorderHealth Systems, Economic Evaluations, Quality of Life
Cited by 56
- Verified
Identifying individuals with undiagnosed post-traumatic stress disorder in a large United States civilian population – a machine learning approach
Gagnon-Sanschagrin, P., Schein, J., Urganus, A., Serra, E., Liang, Y., Musingarimi, P., Cloutier, M., Guérin, A., & Davis, L. L. (2022) · BMC Psychiatry
Posttraumatic Stress Disorder ResearchTraumatic Brain Injury Research
Cited by 28
- Verified
Rivaroxaban versus heparin bridging to warfarin therapy: impact on hospital length of stay and treatment costs for low-risk patients with pulmonary embolism
Weeda, E. R., Kohn, C. G., Peacock, W. F., Fermann, G. J., Crivera, C., Schein, J. R., & Coleman, C. I. (2016) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Venous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and Outcomes
Cited by 15
- Verified
Pulmonary embolism inpatients treated with rivaroxaban had shorter hospital stays and lower costs compared with warfarin
Margolis, J. M., Deitelzweig, S., Kline, J., Tran, O., Smith, D. M., Crivera, C., Bookhart, B., & Schein, J. (2016) · Clinical Therapeutics
Venous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and Outcomes
Cited by 13
- Verified
Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/ hyperactivity disorder
Schein, J., Cloutier, M., Gauthier-Loiselle, M., Bungay, R., Chen, K., Chan, D., & Childress, A. (2024) · Journal of Managed Care & Specialty Pharmacy
Attention Deficit Hyperactivity DisorderHealth Systems, Economic Evaluations, Quality of Life
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free